rs763704682
Your query was ambiguous. Multiple possible variants found:
- chr14-95099771-C-CACAA
- chr14-95099771-C-CACAAAA
- chr14-95099771-C-CACACAA
- chr14-95099771-C-CACACAAAA
- chr14-95099771-C-CACACACAA
- chr14-95099771-C-CACACACAAAA
- chr14-95099771-C-CACACACACAA
- chr14-95099771-C-CACACACACACAA
- chr14-95099771-C-CACACACACACACAA
- chr14-95099771-C-CACACACACACACACAA
- chr14-95099771-C-CACACACACACACACACAA
- chr14-95099771-C-CACACACACACACACACACACACAA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_177438.3(DICER1):c.4206+8_4206+9insTTGT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0528 in 26,826 control chromosomes in the GnomAD database, including 52 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.053 ( 52 hom., cov: 30)
Exomes 𝑓: 0.0045 ( 44 hom. )
Failed GnomAD Quality Control
Consequence
DICER1
NM_177438.3 splice_region, intron
NM_177438.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.425
Publications
2 publications found
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
- DICER1-related tumor predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pleuropulmonary blastomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- DICER1 syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- global developmental delay - lung cysts - overgrowth - Wilms tumor syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 14-95099771-C-CACAA is Benign according to our data. Variant chr14-95099771-C-CACAA is described in ClinVar as Benign. ClinVar VariationId is 221051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0854 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0528 AC: 1413AN: 26746Hom.: 54 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
1413
AN:
26746
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00329 AC: 561AN: 170614 AF XY: 0.00241 show subpopulations
GnomAD2 exomes
AF:
AC:
561
AN:
170614
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00449 AC: 1231AN: 274410Hom.: 44 Cov.: 34 AF XY: 0.00432 AC XY: 581AN XY: 134510 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1231
AN:
274410
Hom.:
Cov.:
34
AF XY:
AC XY:
581
AN XY:
134510
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
750
AN:
12742
American (AMR)
AF:
AC:
92
AN:
4964
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
4586
East Asian (EAS)
AF:
AC:
1
AN:
2420
South Asian (SAS)
AF:
AC:
45
AN:
14506
European-Finnish (FIN)
AF:
AC:
5
AN:
9026
Middle Eastern (MID)
AF:
AC:
11
AN:
1586
European-Non Finnish (NFE)
AF:
AC:
199
AN:
212896
Other (OTH)
AF:
AC:
125
AN:
11684
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.373
Heterozygous variant carriers
0
51
103
154
206
257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0528 AC: 1416AN: 26826Hom.: 52 Cov.: 30 AF XY: 0.0491 AC XY: 640AN XY: 13032 show subpopulations
GnomAD4 genome
AF:
AC:
1416
AN:
26826
Hom.:
Cov.:
30
AF XY:
AC XY:
640
AN XY:
13032
show subpopulations
African (AFR)
AF:
AC:
1237
AN:
13820
American (AMR)
AF:
AC:
128
AN:
2092
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
536
East Asian (EAS)
AF:
AC:
0
AN:
194
South Asian (SAS)
AF:
AC:
2
AN:
684
European-Finnish (FIN)
AF:
AC:
0
AN:
1852
Middle Eastern (MID)
AF:
AC:
0
AN:
70
European-Non Finnish (NFE)
AF:
AC:
24
AN:
7088
Other (OTH)
AF:
AC:
25
AN:
420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
DICER1-related tumor predisposition Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.